HSS Research Institute
Since its founding more than 150 years ago, Hospital for Special Surgery has been a leader in research aimed at improving the lives of patients suffering from debilitating orthopedic and rheumatic conditions such as arthritis, bone and soft tissue injuries, autoimmune diseases, and musculoskeletal pain and deformities.
Today, the HSS Research Institute, with over 225 dedicated personnel, is identifying mechanisms underlying these conditions, and developing effective approaches for prevention, diagnosis, and treatment. With a focus on tissue repair, improving surgical outcomes, autoimmunity and inflammation, genomics, new treatments, and precision medicine, the impact of our discoveries – many of which are only happening at HSS – determine future directions of musculoskeletal research to best improve clinical outcomes.

Active Federal Grants Funding

Publications in 2023

Active Foundation & Industry Funding

Movement is the Essence of Life
We are embarking on a new era of research at HSS by expanding the scope of basic and clinical science and building multidisciplinary translational research teams.
Research Areas
Bone Health and Spine Regeneration
HSS scientists conducting research in this area are uncovering the nature of bone – how it thrives, how it degenerates, and how it interacts with soft tissues like cartilage, ligaments, and tendons, as well as orthopaedic devices such as implants. Understanding the mechanisms that regulate bone structure and function is critical for determining how and why skeletal disorders occur and for developing new treatments for these disorders. Scientists in this area are performing cutting-edge research to enhance mobility and improve quality of life for patients affected by bone disorders such as spine instability, fractures, developmental deformities, arthritis, and osteoporosis.

Arthritis and Tissue Degeneration Program
- Carl Blobel, MD, PhD, Director
The mission of the Arthritis and Tissue Degeneration Program is to define cellular and molecular mechanisms important in musculoskeletal tissue destruction and to develop novel approaches to preventing tissue destruction in patients with arthritis and related diseases.

Musculoskeletal Integrity Program
The Musculoskeletal Integrity Program's mission is to determine the biological, biochemical, and biomechanical mechanisms involved in musculoskeletal tissue development, degeneration, and repair, and to use that information to develop therapies to prevent or correct conditions in which these processes are impaired.
Autoimmunity and Inflammation
The cells of the immune system function together in a highly complex network to protect the body against infections. When control of the immune system is impaired, autoimmunity and tissue damage due to inflammation can result. Scientists in this area are focused on understanding the disease-causing mechanisms and developing more effective therapies. With millions of patients worldwide suffering from rheumatoid arthritis, lupus, and other chronic autoimmune and inflammatory diseases, these scientists are working hard to develop better treatments and, ultimately, cures.

Autoimmunity and Inflammation Program
- Mary K. Crow, MD, Director
The investigators of the Autoimmunity and Inflammation Research Program at Hospital for Special Surgery study the basic mechanisms of immune system function and the role of altered immune system activation, regulation, and effector function in the pathogenesis of the systemic autoimmune and inflammatory diseases.

Arthritis and Tissue Degeneration Program
- Carl Blobel, MD, PhD, Director
The mission of the Arthritis and Tissue Degeneration Program is to define cellular and molecular mechanisms important in musculoskeletal tissue destruction and to develop novel approaches to preventing tissue destruction in patients with arthritis and related diseases.
Precision Medicine
In response to the great promise that precision medicine holds, HSS has created a Precision Medicine Laboratory that will enable the study of disease mechanisms, surgical outcomes, and responses to therapy in specific patient populations. The Laboratory catalyzes the formation of multidisciplinary teams of scientists, physicians, and orthopaedic surgeons, linking clinical research with exciting basic science research. HSS will use the precision medicine approach to pinpoint the most personalized treatment plan for the patient – ultimately allowing physicians to select the right treatment the first time and improving outcomes.

Precision Medicine Laboratory
- Laura Donlin, PhD and Miguel Otero, PhD, Directors
Through the HSS Precision Medicine Laboratory, multidisciplinary clinician-scientist teams comprehensively study orthopedic and autoimmune disorders. Through integrative and cutting-edge approaches, we aim to discover the best treatment for each patient.
Contact Us: 212.774.7123
Events
HSS Research Day took place on Thursday, May 9, 2024 featuring keynote speaker John Varga, M.D., FACP, MACR, Frederick G L Huetwell, Professor of Rheumatology, Professor of Internal Medicine, Chief, Division of Rheumatology, University of Michigan.
HSS Research In the News
- Social Isolation a Common Theme Among Older People With SLE
- Machine learning may assist in identifying pain trajectories after TKA
- HSS Achieves 100% Success Rate for Sedation-Free Pediatric MRIs
- Knee implants may have high long-term survivability in young patients
- Two HSS Studies Exploring Pain Control Win President’s Choice Awards at Annual ASRA Meeting
- HSS Studies Identify Potential Profile and Treatment Options for Mild Traumatic Brain Injury
- HSS Names Kevin M. Koch, PhD, Founding Director of the Applied Sciences Institute and Vice Chair of Research in Radiology
- New Study Reveals Young, Active Patients Who Have Total Knee Replacements are Unlikely to Need Revision Surgery in their Lifetime
- Tibial tubercle transfer associated with low complication risk with, without distalization
- Trials Aim to Show Benefit of Orthobiologic for Knee OA
- GLP-1 receptor agonists may improve outcomes for patients with morbid obesity after TKA
- HSS Participates in Promising Phase 3 Lupus Trial of Investigational Therapy DZP
- Proximal femoral replacement may effectively salvage complex revision THA cases
- Study Shows Knee Osteoarthritis Causes More Pain and Inflammation in Women
- HSS Presents Cutting-Edge Discoveries in Rheumatic Disease and Reproductive Health at ACR Convergence 2024
- Study Shows Avacopan Effective for Most Serious Vasculitis Cases
- Surprising Study Finds No Link Between Rheumatoid Arthritis and Transfusion Risk After Knee Replacement
- New Research Reveals Alterations in Blood of People at Risk of Developing Rheumatoid Arthritis
- HSS Presents New Research at the ACR Convergence 2024
- New Study Signals How Online Search Trends Could Lead to More Personalized Rheumatic Disease Care
- Pregnancy can change your feet forever. Here's the science behind 'mom feet.'
- Novel Drug Candidate Based on HSS Research Secures $70M Series A Financing and Will Begin Its First Clinical Trial in Europe
- HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery
- Dr. Kyle Kunze- Growing in Residency
- Liposomal bupivacaine may augment pain management for spinal fusion
- HSS Celebrates Women's History Month (Dr. Suzanne Maher)
- Self-reported nickel allergy may not impact outcomes after TKA
- ChatGPT-4 may provide accurate, reliable patient information on the Latarjet procedure
- New HSS Studies Highlight the Benefits of Robotic-Assisted Joint Replacement Surgery
- HSS Presents Research at 2024 AAOS Annual Meeting
- HSS Research Evaluates Whether AI Chatbots Provide Reliable Medical Information
- Meet Us At Tomorrow: Discovery, Learning, & Leadership for the Future of Orthopaedics (HSS)
- Study Assesses Sarilumab for Polymyalgia Rheumatica
- HSS Study Reveals Concerning Link Between Growth Hormone Therapy and Growth Plate Fractures in Children
- Dr. Elizabeth Gausden joins Doctor Podcast
- Revamped ACR-EULAR Antiphospholipid Syndrome Classification Criteria: What Do They Mean for Clinical Research?
- HSS to Harness Surge in Artificial Intelligence Applications and Democratize High Quality Healthcare
- HSS Researchers Enable Study Identifying Subtypes of Rheumatoid Arthritis
- HSS Presents New Reproductive Health Research at the ACR Convergence 2023
- HSS Shares Strategies to Enhance and Enable Communication with Language-Diverse Patients at Annual ACR Convergence
- New Antiphospholipid Syndrome Research Findings Presented at ACR Convergence 2023
- New Study Identifies Outcomes Associated With Frailty in Patients With Vasculitis
- New Study Shows Perception of Aging is Linked to Level of Physical Activity in Arthritis Patients
- Study Finds People with Inflammatory Arthritis Face Significant Psychological Challenges in Maintaining Employment
- HSS Research Shows Obesity Is Associated with Worse Flare Symptoms and Quality of Life in People with Early Rheumatoid Arthritis
- HSS Presents New Research at the ACR Convergence 2023
- A High-Risk Antiphospholipid Antibody Profile Matters in Pediatric Patients with Antiphospholipid Syndrome
- Stem Cell Discovery Could Revolutionize Spine and Cancer Care
- Hospital for Special Surgery, Weill Cornell researchers discover spine-specific stem cell
- Study Published in Nature Reveals Discovery of Unique Vertebral Stem Cells with Potential to Revolutionize Patient Care